Article

Divergent resistance mechanisms to immunotherapy explains response in different skin cancers

2020-09-15

Abstract excerpt

The advent of immune checkpoint therapy for metastatic skin cancer has greatly improved patient survival. However, most skin cancer patients are refractory to checkpoint therapy, and furthermore the differential intra-immune signaling between cancers driving the response to checkpoint therapy remains uncharacterized. When comparing the immune transcriptome in the tumor microenvironment of melanoma and basal cell c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f6f69bb5-2ab0-5c7f-b4d8-803bebb911cb
DOI: 10.1101/2020.09.15.298182

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Divergent resistance mechanisms to immunotherapy explains response in different skin cancersDOI 10.1101/2020.09.15.298182Read

Genomic landscape of the immunogenicity regulation in skin melanomas with diverse tumor mutation burden.Semantic proximity Read

OMIC signatures to understand cancer immunosurveillance and immunoediting: Melanoma and immune cells interplay in immunotherapySemantic proximity Read

Genetic and Environmental Determinants of Immune Response to Cutaneous MelanomaSemantic proximity Read

Signaling and Immune Regulation in Melanoma Development and Responses to TherapySemantic proximity Read

Insights and Strategies of Melanoma Immunotherapy: Predictive Biomarkers of Response and Resistance and Strategies to Improve Response RatesSemantic proximity Read

Biological Factors behind Melanoma Response to Immune Checkpoint Inhibitors.Semantic proximity Read

Prediction of immunotherapy responsiveness in melanoma through single-cell sequencing-based characterization of the tumor immune microenvironmentSemantic proximity Read

Correlation of tumor-infiltrating immune cells of melanoma with overall survival by immunogenomic analysis.Semantic proximity Read

Multi-model preclinical platform predicts clinical response of melanoma to immunotherapySemantic proximity Read

Decitabine reverses innate immune gene suppression in rare melanomasSemantic proximity Read

Comprehensive Analysis of the Tumor Microenvironment in Cutaneous Melanoma associated with Immune InfiltrationSemantic proximity Read

Systematic evaluation of the predictive gene expression signatures of immune checkpoint inhibitors in metastatic melanomaSemantic proximity Read